Observational study of stroke management and outcomes at Akershus University Hospital
The Akershus Study of Ischemic Stroke and Thrombolysis -1 (ASIST-1) Epidemiology, Clinical and Radiological Presentation and Treatment of Cerebrovascular Disease and Stroke Mimics in a Norwegian Population
This study looks at how patients with strokes are treated at Akershus University Hospital to see how well different treatments work and why some patients don’t receive certain therapies.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 6000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Akershus Academic / other |
| Locations | 1 site (Lørenskog) |
| Trial ID | NCT05378490 on ClinicalTrials.gov |
What this trial studies
This observational study involves patients with cerebrovascular diseases admitted to the Stroke Unit at Akershus University Hospital in Norway. The study aims to evaluate the use of the stroke fast track, the proportion of patients treated with intravenous thrombolysis, and the reasons for not administering thrombolysis in eligible patients. It will also investigate outcomes for patients treated or not treated with thrombolysis, as well as differences between stroke types and mimics. The research will provide insights into stroke management and care pathways in a comprehensive stroke center.
Who should consider this trial
Good fit: Ideal candidates include individuals experiencing acute ischemic stroke, intracerebral hemorrhage, transient ischemic attack, or stroke mimics.
Not a fit: Patients with chronic cerebrovascular conditions or those not presenting with acute symptoms may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve stroke management protocols and patient outcomes in acute care settings.
How similar studies have performed: Other studies have shown success in evaluating stroke management protocols, indicating that this approach is supported by existing research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Cerebrovascular diseases (acute ischemic stroke, intracerebral hemorrhage, transient ischemic attack) or stroke mimics Exclusion Criteria: * None
Where this trial is running
Lørenskog
- Akershus University Hospital — Lørenskog, Norway (Recruiting)
Study contacts
- Principal investigator: Espen S. Kristoffersen, MD, PhD — University Hospital, Akershus
- Study coordinator: Espen S. Kristoffersen, MD, PhD
- Email: e.s.kristoffersen@medisin.uio.no
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.